Earnings Feed
Start Free
Home/Filings/4/0001127602-22-011633
4//SEC Filing

Lynch Karen S 4

Accession 0001127602-22-011633

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 7:23 PM ET

Size

14.9 KB

Accession

0001127602-22-011633

Insider Transaction Report

Form 4
Period: 2022-04-01
CVS HEALTH CorpCVS
Rohan Karen
EVP & Pres, Aetna Bus Unit
Transactions
  • Tax Payment

    Common Stock

    2022-04-01$101.09/sh−116,940$11,821,465→ 210,090 total
  • Award

    Stock Option

    2022-04-01$101.09/sh+171,517$17,338,654→ 171,517 total
    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (171,517 underlying)
Holdings

  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (224,604 underlying)
    224,604

  • Stock Appreciation Rights

    Exercise: $37.91From: 2019-02-19Exp: 2026-02-18→ Common Stock (93,989 underlying)
    93,989

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (242,408 underlying)
    242,408

  • Common Stock (By Trust)

    94,369

  • Stock Appreciation Rights

    Exercise: $45.91From: 2019-02-17Exp: 2027-02-16→ Common Stock (192,741 underlying)
    192,741

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (211,196 underlying)
    211,196
Footnotes (8)
  • [F1]Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022.
  • [F2]Option becomes exercisable in four equal installments, commencing 4/1/2023.
  • [F3]Represents unvested Aetna Inc. Stock Appreciation Rights ("SARs") granted under the Aetna Plan on February 17, 2017 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vest in two substantially equal annual installments beginning on February 17, 2019.
  • [F4]Represents unvested SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F6]The number of shares subject to the option were calculated using a 30-day average price.
  • [F7]Options became exercisable in four equal installments, commencing 4/1/2021.
  • [F8]Option becomes exercisable in four equal installments, commencing 4/1/2022.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001333760

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 7:23 PM ET
Size
14.9 KB
View on SEC.gov